Video interviews of experts in the field reviewing research being presented at the 2022 AUA Annual Meeting.
EP. 1: 2022 AUA preview: Dr. Pearlman on top research in sexual dysfunction and infertility
Amy M. Pearlman, MD, highlights 6 studies in sexual dysfunction and infertility being presented at the 2022 American Urological Association Annual Meeting.
EP. 2: 2022 AUA preview: Dr. Krambeck on top research in BPH and urinary stones
Amy Krambeck, MD, highlights 6 studies in BPH and urinary stones being presented at the 2022 American Urological Association Annual Meeting.
EP. 3: 2022 AUA preview: Dr. Almassi on top research in bladder cancer
Nima Almassi, MD, highlights 5 studies in bladder cancer being presented at the 2022 American Urological Association Annual Meeting.
EP. 4: 2022 AUA preview: Dr. Schwen on top research in prostate cancer
Zeyad Schwen, MD, highlights 5 studies in prostate cancer being presented at the 2022 American Urological Association Annual Meeting.
NIAGARA: ctDNA analysis highlights durvalumab’s impact in MIBC
Nivolumab/ipilimumab continues to show improved survival, durable response in aRCC
Mixed results reported for nivolumab/ipilimumab in cisplatin-ineligible mUC
EV plus pembrolizumab doubles CR rate vs chemotherapy in la/mUC
